Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Dautzenberg et al (2007)
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Gisleskog et al (2021)
Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Le Houezec (2003)
Randomized Comparative Trial of Nicotine Polacrilex, a Transdermal Patch, Nasal Spray, and an Inhaler.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Hajek et al (1999)
Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and abstention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
St.helen (2020)
an Examination of Differences in acute Nicotine Withdrawal Symptoms between Electronic Nicotine Delivery System and Combustible Cigarette Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Versella (2022)